Triple-negative breast cancer (TNBC) represents a distinct and aggressive subtype of breast cancer, defined by the absence of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) expression [3,4]. This evidence concerns the gene ERBB2 and breast carcinoma.